Response of Hepatocellular Carcinoma to Percutaneous Ethanol Injection
- 1 September 1993
- journal article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 17 (5) , 723-729
- https://doi.org/10.1097/00004728-199309000-00011
Abstract
Objective: The aim of the present study was to perform a comparative assessment of the contribution of imaging examinations to the evaluation of the response of hepatocellular carcinoma (HCC) to percutaneous ethanol injection (PEI). Materials and Methods: Twenty-five small HCCs (< 5 cm in diameter) were treated by means of PEI. The outcome of treatment, established on the basis of percutaneous biopsy and a 10 to 26 month follow-up, was complete necrosis in 23 of 25 cases and tumor persistence in 2 of 25. Results: While ultrasound proved to be unable to distinguish posttreatment fibrosis from persisting neoplastic tissue, contrast-enhanced CT correctly identified the two cases of treatment failure, which showed the presence of enhancing areas within the lesion. The remaining 23 cases displayed a hypodense appearance, with no contrast enhancement on CT. Magnetic resonance demonstrated ethanol-induced coagulative necrosis as marked hypointensity on T2-weighted images in 21 of 25 cases. In four cases areas of high signal intensity on T2-weighted images within the nodule were observed after PEI: In two cases they were associated with tumor persistence, and in the other two with the presence of liquefactive necrosis. Conclusion: Our results demonstrate that different necrotic phenomena following ethanol injection therapy of HCCs may result in variable MR appearance. Although the location of hyperintense areas may suggest a differential diagnosis (central hyperintensity being more likely due to necrosis), CT remains the more reliable technique in the assessment of the response of HCC to PEIKeywords
This publication has 0 references indexed in Scilit: